OXYVITA Revenue and Competitors

New Windsor, NY USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OXYVITA's estimated annual revenue is currently $620k per year.(i)
  • OXYVITA's estimated revenue per employee is $155,000

Employee Data

  • OXYVITA has 4 Employees.(i)
  • OXYVITA grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is OXYVITA?

OXYVITA Inc. is a biotech company specializing in developing oxygen therapeutics and biomedical products utilizing our proprietary Zero-Linkâ„¢ hemoglobin polymerization process. OxyVita is a polymerized stroma free hemoglobin. This polymeric hemoglobin solution, which is clinically useful as a blood substitute due to its oxygen carrying function, can dramatically reduce the need for blood donated by human donors and significantly reduce the risks associated with blood transfusions. OXYVITA Inc. is now significantly advanced in preclinical trials and will be seeking to progress into clinical trials upon FDA approval. Current fund raising is geared at funding the remaining animal trials and FDA application endeavors. We continue to supply product to independent researchers for further evaluation of potential applications. OXYVITA Inc. had recently entered into a CRADA (Collaborative Research and Development Agreement with the U.S. Navy.

keywords:N/A

N/A

Total Funding

4

Number of Employees

$620k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M50%N/A
#2
$0.6M80%N/A
#3
$0.7M80%N/A
#4
$1.3M1536%N/A
#5
$4.7M25-4%N/A